Cart
sales@molnova.com
Bendazac
CAS No. 20187-55-7
Bendazac ( Bendazolic acid;AF-983 )
Catalog No. M21078 CAS No. 20187-55-7
Bendazac is an anticataract drug. It may act by preventing protein denaturation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 37 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBendazac
-
NoteResearch use only not for human use.
-
Brief DescriptionBendazac is an anticataract drug. It may act by preventing protein denaturation.
-
DescriptionBendazac is an anticataract drug. It may act by preventing protein denaturation.
-
SynonymsBendazolic acid;AF-983
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number20187-55-7
-
Formula Weight282.29
-
Molecular FormulaC16H14N2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:56 mg/mL (198.38 mM)
-
SMILESO=C(O)COc1nn(Cc2ccccc2)c2ccccc12
-
Chemical Name2-((1-benzyl-1H-indazol-3-yl)oxy)acetic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Marques C Ramalho J S Pereira P et al. Bendazac decreases in vitro glycation of human lens crystallins. Decrease of in vitro protein glycation by bendazac[J]. Documenta Ophthalmologica 1995 90(4):395-404.
molnova catalog
related products
-
3-O-Acetyl-20-Hydrox...
3-O-Acetyl-20-Hydroxyecdysone is an steroid isolated from the roots of Cyanotis arachnoidea C.B.Clark.
-
RTICBM-189
RTICBM-189 is Brain Penetrant and Attenuates Reinstatement of Cocaine-Seeking Behavior.
-
Epitinib succinate
Epitinib succinate is an orally active and selective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) designed for optimal brain penetration. Epitinib succinate can be used for the research of cancer.
